Patents by Inventor Srijani Sridhar

Srijani Sridhar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Reducing HLA-A in a Cell
    Publication number: 20240024478
    Abstract: Compositions and methods for reducing HLA-A protein expression in a cell comprising genetically modifying HLA-A for use e.g., in adoptive cell transfer therapies.
    Type: Application
    Filed: June 22, 2023
    Publication date: January 25, 2024
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Surbhi Goel, Yong Zhang, Reynald Michael Lescarbeau, Bradley Andrew Murray, Srijani Sridhar
  • Compositions and Methods for Reducing MHC Class II in a Cell
    Publication number: 20240016934
    Abstract: Compositions and methods for reducing MHC class II protein expression in a cell comprising genetically modifying CIITA for use e.g., in adoptive cell transfer therapies.
    Type: Application
    Filed: June 9, 2023
    Publication date: January 18, 2024
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Srijani Sridhar, Yong Zhang, William Frederick Harrington, Surbhi Goel
  • Compositions and Methods for Lactate Dehydrogenase (LDHA) Gene Editing
    Publication number: 20210222173
    Abstract: Compositions and methods for editing, e.g., introducing double-stranded breaks, within the LDHA gene are provided. Compositions and methods for treating subjects having hyperoxaluria are provided.
    Type: Application
    Filed: March 25, 2021
    Publication date: July 22, 2021
    Applicant: Intellia Therapeutics, Inc.
    Inventors: Zachary William Dymek, Shobu Odate, Anette Huebner, Srijani Sridhar, Bradley Andrew Murray, Walter Strapps